Results 181 to 190 of about 19,651 (218)

Long-Term Real-World Impact of Cardiac Myosin Inhibitors on Diastolic Function in Hypertrophic Cardiomyopathy Patients [PDF]

Aakash Bavishi, John Fritzlen, Marybeth Soutar, Kutaiba Nazif, Francisco Gonzalez, Matthew W. Martinez   +5 more
openalex   +1 more source

Efficacy and safety of mavacamten in non-obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis of randomized trials. [PDF]

Int J Cardiol Heart Vasc
Abdullah M, Thalib HI, Tahir MB, Khalid N, Mushtaq A, Afzal MA, Moore MD, Sharma N, Muddassir S, Ayers MP, Albaghdadi M, Aronow WS.   +11 more
europepmc   +1 more source

Hypertrophic Cardiomyopathy Mutation R723G in MYH7 Enhances Its mRNA‐Stability

Acta Physiologica, Volume 242, Issue 6, June 2026.
Kathrin Kowalski, Luisa Schwarze, Theresia Kraft, Judith Montag   +3 more
wiley   +1 more source

Myosin Modulators Mavacamten and Aficamten Inhibit Cardiac Contractility Through Different Mechanisms

Saffie Mohran, Kristina B. Kooiker, Galina Flint, Max Mahoney-Schaefer, Weikang Ma, Timothy S. McMillen, Thomas C. Irving, Michael Regnier, Farid Moussavi‐Harami   +8 more
openalex   +1 more source

Osimertinib induces reversible cardiac dysfunction through the GATA4-MYLK3-MYL2 axis. [PDF]

Eur Heart J
Zhang K, Ayala A, Norambuena-Soto I, Agnihotri V, Shu T, Nenninger C, Wang Y, Echevarria B, Aboagye J, Huang K, Espitia-Corredor J, Wu X, Chen ZB, Deng Y, Perry JJP, Raz DJ, Yang H, Cheng P, Fu G, Wang ZV, Rhee JW.   +20 more
europepmc   +1 more source

2026 Expert Consensus Recommendations on Hypertrophic Cardiomyopathy: A Report of the Task Force of the Taiwan Society of Cardiology. [PDF]

Acta Cardiol Sin
Hung CL, Wu YW, Lai CH, Chen ML, Liang HY, Kuo L, Wang CL, Tseng H, Juang JJ, Liu YW, Tsai WC, Chang HY, Chang WT, Chen PS, Hsieh IC, Yu WC, Li YH.   +16 more
europepmc   +1 more source

Recent trend in the therapy of hypertrophic cardiomyopathy: Cardiac myosin inhibitors

, 2023
Cahit Demirkiran, Şeniz Demiryürek, Abdullah Tuncay Demiryürek   +2 more
openalex   +1 more source

Rho/ROCK Signaling Pathway in Kidney Diseases: Mechanisms and Therapeutic Perspectives. [PDF]

Biomedicines
Xiong W, Miao D, Hou Z, Zhang X, Xiong Z.   +4 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Early fibrotic gene activation precedes structural remodeling in the heart of cardiac myosin binding protein-C knockout mice. [PDF]

Physiol Genomics
Turner KL, Christopherson TG, Tanner BCW.   +2 more
europepmc   +1 more source